Evaluation of the implementation effect of hepatitis C medical insurance reimbursement policy in China: A RWS based on medical institutions.

Liu, Yiyao; Gou, Liangwen; Guo, Zhaoting; Wu, Zhiang; He, Qin; Feng, Haihuan; Hu, Ming

Liu, Yiyao; Gou, Liangwen; Guo, Zhaoting; Wu, Zhiang; He, Qin; Feng, Haihuan; Hu, Ming.

Afiliación

Liu Y; West China School of Pharmacy, Sichuan University, Chengdu, China.
Gou L; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
Guo Z; West China School of Pharmacy, Sichuan University, Chengdu, China.
Wu Z; West China School of Pharmacy, Sichuan University, Chengdu, China.
He Q; Yeehong Business School, Shenyang Pharmaceutical University, Beijing, China.
Feng H; West China School of Pharmacy, Sichuan University, Chengdu, China.
Hu M; Medical Insurance Office, West China Hospital of Sichuan University, Chengdu, China.

Front Public Health ; 10: 1072493, 2022.

Article en En | MEDLINE | ID: mdl-36711333

Asunto(s)

Antivirales; Hepatitis C; Humanos; Antivirales/uso terapéutico; Seguro de Salud; Gastos en Salud; Políticas; Hepacivirus; Hepatitis C/tratamiento farmacológico

Palabras clave

hepatitis C; interrupted time series analysis; medical insurance; policy analysis; real data analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C Tipo de estudio: Evaluation_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google